| |
| |
|
| Insider
Information: |
Garland J. Scott |
| Relationship: |
President and CEO, Dir... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Relypsa Inc |
RLYP |
SVP & Chief Commercial... |
2016-09-01 |
0 |
2015-08-10 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
President and CEO, Dir... |
2020-07-02 |
0 |
2018-10-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTLA |
Portola Pharmaceuticals I... |
President and CEO |
• • – |
2020-07-02 |
4 |
D |
$18.00 |
$462,636 |
D/D |
(25,702) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
President and CEO |
• • – |
2020-06-18 |
4 |
A |
$8.36 |
$9,806 |
D/D |
1,173 |
1,173 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
President and CEO |
• • – |
2020-02-03 |
4 |
D |
$12.89 |
$72,480 |
D/D |
(5,623) |
177,928 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
President and CEO |
• • – |
2020-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
183,551 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
President and CEO |
• • – |
2019-11-01 |
4 |
D |
$29.84 |
$643,022 |
D/D |
(21,549) |
133,551 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
President and CEO |
• • – |
2019-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
30,100 |
155,100 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
President and CEO |
• • – |
2018-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
125,000 |
0 |
- |
|
| RLYP |
Relypsa Inc |
SVP & Chief Commercial Officer |
• – – |
2016-09-01 |
4 |
D |
$32.00 |
$513,344 |
D/D |
(16,042) |
0 |
0 |
- |
|
| RLYP |
Relypsa Inc |
SVP & Chief Commercial Officer |
• – – |
2016-09-01 |
4 |
D |
$32.00 |
$79,040 |
D/D |
(2,470) |
16,042 |
0 |
- |
|
| RLYP |
Relypsa Inc |
SVP & Chief Commercial Officer |
• – – |
2016-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,167 |
18,512 |
0 |
- |
|
| RLYP |
Relypsa Inc |
SVP & Chief Commercial Officer |
• – – |
2016-08-15 |
4 |
D |
$31.89 |
$22,482 |
D/D |
(705) |
14,345 |
0 |
- |
|
| RLYP |
Relypsa Inc |
SVP & Chief Commercial Officer |
• – – |
2016-06-03 |
4 |
D |
$19.96 |
$15,629 |
D/D |
(783) |
15,050 |
0 |
- |
|
| RLYP |
Relypsa Inc |
SVP & Chief Commercial Officer |
• – – |
2016-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,083 |
15,833 |
0 |
- |
|
| RLYP |
Relypsa Inc |
SVP & Chief Commercial Officer |
• – – |
2015-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
13,750 |
0 |
- |
|
| RLYP |
Relypsa Inc |
SVP & Chief Commercial Officer |
• – – |
2015-08-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
7,500 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
